Search

Your search keyword '"Murhekar, Manoj V."' showing total 343 results

Search Constraints

Start Over You searched for: Author "Murhekar, Manoj V." Remove constraint Author: "Murhekar, Manoj V."
343 results on '"Murhekar, Manoj V."'

Search Results

1. Need for operational simplicity and timely disbursal of benefits—a qualitative exploration of the implementation of a direct benefit transfer scheme for persons with tuberculosis in India

2. Direct benefit transfer for nutritional support of patients with TB in India—analysis of national TB program data of 3.7 million patients, 2018–2022

3. India's 2021 differentiated TB care guidance: Is it feasible to implement and act upon?

4. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018–2020

5. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study

7. Outbreak of ceftriaxone-resistant Salmonella enterica serotype Typhi-Tiruchirappalli, Tamil Nadu, India, June 2018

8. Triaging for Severe Illness amongst Adults with Tuberculosis Followed by Referral and Inpatient Care: A Statewide Pilot in Tamil Nadu, India

9. Baseline findings of a multicentric ambispective cohort study (2021–2022) among hospitalised mucormycosis patients in India

11. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021

12. Immunity against diphtheria among children aged 5–17 years in India, 2017–18: a cross-sectional, population-based serosurvey

13. SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

14. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18

16. Quality of active case-finding for tuberculosis in India: a national level secondary data analysis

17. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey

18. Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women

19. Protocol for establishing a model for integrated influenza surveillance in Tamil Nadu, India

20. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study

23. Infections among Contacts of Patients with Nipah Virus, India

25. Burden of Typhoid and Paratyphoid Fever in India

26. The First Differentiated TB Care Model From India: Delays and Predictors of Losses in the Care Cascade

27. A community-based study of dental fluorosis in rural children (6–12 years) from an aspirational district in Karnataka, India

28. ­­Eleven tips for operational researchers working with health programmes: our experience based on implementing differentiated tuberculosis care in south India

29. Socio-Economic, Demographic and Behavioral Factors Associated with Dengue Outbreak: An Observational Study from Eastern Uttar Pradesh, India

33. Corrigendum to ‘Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis’ [International Journal of Infectious Diseases, Volume 116 (2022) P59-67]

34. Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (Covishield™) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021

37. Added Value of the Measles-Rubella Supplementary Immunization Activity in Reaching Unvaccinated and Under-Vaccinated Children, a Cross-Sectional Study in Five Indian Districts, 2018-20

38. Measles and Rubella Seroprevalence to Evaluate the Impact of the Mass Vaccination Campaigns in India: Pre-And Post- Cross-Sectional Household Serosurveys in Four Indian Districts, 2018-2020

42. Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020

44. Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations

45. Scrub typhus as a cause of acute encephalitis syndrome, Gorakhpur, Uttar Pradesh, India

46. Secondary attack rate of COVID-19 among contacts and risk factors, Tamil Nadu, March–May 2020: a retrospective cohort study

47. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states/Exposition frequente a des temperatures suboptimales dans la chaine du froid des vaccins en Inde:

48. Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies

50. Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20

Catalog

Books, media, physical & digital resources